Pembrolizumab Utilization and Clinical Outcomes Among Patients With Advanced Melanoma in the US Community Oncology Setting: An Updated Analysis

Favorable outcomes have been observed with pembrolizumab among patients with advanced melanoma in clinical trials; however, limited evidence exists on the long-term efficacy in the real-world setting. This was an updated, retrospective observational study of adult patients with advanced (unresectabl...

Descripción completa

Detalles Bibliográficos
Autores principales: Cowey, Charles Lance, Scherrer, Emilie, Boyd, Marley, Aguilar, Kathleen M., Beeks, April, Krepler, Clemens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Clinical Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8191741/
https://www.ncbi.nlm.nih.gov/pubmed/33734142
http://dx.doi.org/10.1097/CJI.0000000000000363

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8191741/
https://www.ncbi.nlm.nih.gov/pubmed/33734142
http://dx.doi.org/10.1097/CJI.0000000000000363

Ejemplares similares